Introduction: Diabetes mellitus (DM) has been a growing epidemic worldwide and poses a major socio-economic challenge. The leading cause of DM death is nephropathy due to end-stage renal disease (ESRD). This study aims to identify the possible association of I/D variants of the ACE gene and M268T (rs699) of the AGT gene of renin-angiotensinaldosterone system (RAAS). Materials and methods: Study subjects include 115 patients with DM, 110 with diabetic nephropathy (DN) and 110 controls. Fasting blood samples were collected for biochemical analyses and PCR amplification of specific regions of the ACE and AGT genes using primers. Results: The distribution of ACE (I/D) II 28.8%, ID 35.6% and DD 35.6% while in DN II 24.5%, ID 41% and DD 34.5%. The AGT (M268T) genotypes were distributed in DM as TT 30.4%, MT 66.9% and MM 2.6% while in DN subjects TT 56.4%, MT 42.7% and MM 0.9%. Conclusion: Significant differences were observed in the DD genotype and D allele of the ACE gene and the TT genotype and T allele of AGT genes between diabetic patients with and without nephropathy. The study may conclude that the D allele polymorphism in the ACE gene and the T allele polymorphism in AGT gene may be considered as genetic risk factors for the development of nephropathy in diabetes.
Introduction
Diabetes mellitus (DM) is a growing public health disease, which affects people worldwide both in developing as well as developed nations. DM is a chronic disease which causes long-term complications which include macrovascular and microvascular complications. Microvascular complications are diabetic nephropathy (DN), neuropathy and retinopathy. DN has been among the top causes of end-stage renal disease (ESRD) and deaths in DM. 1 In DN a major decrease in glomerular filtration rate (GFR) with increased blood pressure and risk of cardiovascular diseases occurs due to a rise in the excretion of proteins in urine. 2 In DM due to loss of kidney functions, ESRD prevalence has been increasing worldwide. 3 In the progression of DM and its complications many risk factors are involved, which include chronic hyperglycaemia, 4 hypertension, 5 dyslipidemia, 6 smoking, 7 obesity, aging, and insulin resistance. 8 Genetic polymorphisms contribute to progression of DM and its complications. In the renin-angiotensin-aldosterone system (RAAS), angiotensinogen (AGT), angiotensin receptor, 9 and angiotensin-converting enzyme (ACE) gene polymorphisms have thought to be associated with the pathophysiology of DN. 10 The ACE gene is localized on the long arm of chromosome 17 (17q23) and contains 26 exons. The amino acid domain of the ACE enzyme is coded by exon 1 to exon 12, while the carboxyl domain is coded by exon 13 to exon 26. In intron 16 of the ACE gene 287bp alurepetitive sequences has been reported and results in genetic variation in this gene which creates insertion (II) and deletion (DD) homozygous genotypes, and the insertion/deletion (ID) heterozygous genotype. 11 These genetic variations are responsible for the variability in gene function, while it has been reported that deletion is responsible for high activity of the enzyme. 12 The reduced function of the ACE enzyme causes increased insulin-stimulated hexose transport in adipocytes 13 and insulin suppression of non-esterified fatty acid flux. 14 The AGT gene is localized on the long arm of chromosome 1(1q42-43), which consists of five exons. 15 It has more than 23 variants which have been linked with hypertension. 16 The association between AGT M268T (rs699) gene polymorphisms and cardiovascular disorders has been identified in various studies. 17 An increase in levels of angiotensinogen in the T268 homozygous variant leads to an increase in blood pressure. 18 Linkage disequilibrium was found between AGT M268T with T207M and promoter region A-G polymorphisms. Haplotype analysis of AGT T207M and M268T revealed a significant association with hypertension among the Caucasian and Taiwan Chinese populations. 19 By considering the importance of RAAS and the role of ACE and AGT gene variations in various cellular mechanisms, this study aimed to identify the contribution of genetic variations in genes (ACE and AGT) that code the angiotensin-converting enzyme and angiotensinogen in DM and DN patients in Pakistan.
Materials and methods
Following the approval of Institutional ethical board, fasting blood samples (5 ml) from patients and controls were collected in a vacutainer tubes containing acid citrate dextrose (ACD). Study subjects were divided in to three groups: 110 healthy individuals as control, 115 DM patients and 110 DM patients with nephropathy (DN) or any sign of renal insufficiency.
Demographic features and clinical parameters of control and patients were recorded (Table 1 ). Demographic features include age (years), body mass index (BMI) (Kg/m 2 ), systolic blood pressure (SBP) (mmHg), diastolic blood pressure (DBP) (mmHg) and diabetic age (years). The clinical characteristics include glycemic status, lipid profile and renal functions. Blood glucose (fasting and random) (mg/dl) was done by the glucose oxidase method, 20 HbA1c (%) was estimated using the fast ion-exchange resin separation method (Human Gessellschaft fur Biochemica und Diagnostica mbH, Germany). HDL-cholesterol (mg/dl), 21 LDL-cholesterol (mg/dl), 22 serum triglycerides (mg/dl) 23 and serum cholesterol (mg/dl) 24 were estimated by the enzymatic colorimetric method. Jaffe's method 25 was used to estimate serum creatinine (mg/dl), while serum urea (mg/dl) was observed using the diacetyle moxime method 26 and GFR (ml/min) was calculated using a prediction equation. 27 DNA extraction from blood samples was performed using phenol chloroform extraction methods. The I/D polymorphism of ACE gene was observed by standard polymerase chain reaction (PCR) using multi block system (Thermo Hybaid, USA). The flanking primer pair used were 5'-CTGGAGAGCCACTCCCATCCTTTCT3' as forward primer and 5'-GACGTGGCCATCACATTCGTCAGAT3' as reverse primer. The optimized reaction conditions consisted of 20 µl of reaction mixture which contains 250 ng (Figure 1 and 2) . Investigation of the M268T (rs699) polymorphism of the AGT gene was done using Amplification Refractory Mutation System (ARMS) PCR in a multi block system (Thermo Hybaid, USA). A pair of outer and a pair of inner primers were designed using Primer-3 for amplification of specific regions. The sequence for the forward outer was 5'TTGTGCAGGGCCTGGCTCTCTATACCCC3', and for the reverse outer 5'CTCAAGGGTGGTCACCAGGTA TGTCCGC3'; inner primers were forward inner 5'GACA GGATGGAAGACTGGCTGCTCCCTTAC3' and reverse inner 5'CCAGGGTGCTGTCCACACTGGCTCACA3'. The reaction was carried out in a total volume of 20 µl in standard PCR Buffer containing 250 ng DNA, 2 mM of dNTPs (Fermentas), 50 mM MgCl 2 , 20 µM of each primer,1.25 units (5U/µL) Taq Polymerase (Fermentas) in 10× PCR Buffer. The cycling conditions for PCR were initial denaturation at 94°C for 5 min 1 cycle, followed by 25 cycles of 94°C for 1 min (melting), 61°C for 1 min (annealing), 72°C for 1 min (extension) and final extension at 72°C for 6 min. The amplified PCR products were observed on 2% agarose gel.
SPSS statistical package version 16.0 for Windows (SPSS Inc., Chicago, Illinois, USA) was used for statistical analysis. Results were presented as mean±SEM. Students t-test was used to identify the statistical comparison between groups. Hardy-Weinberg equilibrium was assessed using the Yates' corrected chi-square test for identifying the difference in genotype and allele frequencies between groups. Statistical significance was defined as standard 5% level (p<0.05).
Results
Demographic features indicate that the diabetic age was significantly high (p<0.05) in DN subjects as compared with DM without nephropathy. Glycemic status has shown a significant increase (p<0.05) in fasting blood glucose (FBG) (mg/dl) of DM and DN patients as compared with controls, while HbA1c (%) was comparatively high (p<0.05) in DN patients when compared with control and DM. In the lipid profile significant differences (p<0.05) were observed in HDL-cholesterol (mg/dl) and serum triglyceride (mg/dl) of patients with DM without nephropathy and DN when compared with controls. Renal functions showed a significant rise (p<0.05) in serum urea (mg/dl) and serum creatinine (mg/dl) of DM and DN when compared with control.
The genotype (II, ID and DD) and allele (I and D) frequencies of I/D polymorphism in ACE gene of all groups are shown in Table 2 . Results indicate a significant difference (p<0.05) between control and DM (χ 2 =11.311, p=0.003, CI= 0.002-0.004) ( Table 3) . A significant difference (p<0.05) was also observed when the control group was compared with DN (χ 2 =9.627, p=0.009, CI=0.007-0.011). No difference was observed in genotype and allele frequencies between patients with DM and DN (χ 2 =0.789, p=0.668, CI=0.658-0.677).
For AGT gene polymorphism the genotype (TT, MT and MM) and allele (T and M) frequencies of M268T polymorphism are described in Table 4 . Results indicate a significant difference (p<0.05) between controls and DM (χ 2 =56.917, p=0.000, CI=0.000-0.000) ( Table 5 ). Controls and patients with DN has also showed a significant difference (p<0.05) in genotype and allele frequencies (χ 2 =48.651, p=0.000, CI=0.000-0.000). When DM and DN patients were compared, they also showed a significant difference (p<0.05) in genotype and allele frequencies (χ 2 =15.670, p=0.000, CI=0.000-0.000).
Discussion
DN is the major cause of chronic renal disease in patients starting renal replacement therapy. 28 Pathophysiological causes of the onset and progression of DN are not well known; ACE gene polymorphism has been suggested to be important in DN development and progression. 29 The renal prognosis and survival of patients with DN has greatly improved over the past few decades due to antihypertensive treatment. 30 Conflicting findings in different populations on the association between (I/D) polymorphism in the ACE gene and DN led us to investigate this as an important risk factor for the development of hypertension and nephropathy in DM. Wide inter-ethnic allelic variations of the I/D polymorphism of ACE gene were assumed to be responsible for the contradictory gene-diabetic nephropathy disease association globally. 31 The I/D polymorphism of the ACE gene and association with DN was positively identified in Japan 32, 33 and South India, 34 while no association was found in Iran 35 and Malaysia. 31 A recent study found no significant association of ACE I/D polymorphism in the patients with DN in genotype, allele, dominant and recessive models. 36 This study finds significant differences in genotype and alleles when control subjects were compared with patients with DM and DN ( Table 3 ). The DD genotype was found to be high in both groups of patients. FBG was found to be high in patients of DM and DN when compared with controls, and HbA1c was also increased in DN subjects. HDLcholesterol, serum triglyceride, serum creatinine and serum urea levels were also raised in DM patients with and without nephropathy as compared with controls.
The role of variants of AGT (rs699) has been studied in various ethnic groups, and variable results were reported. 37 The positive association of TT genotype of M268T polymorphism with high blood pressure has been identified in Brazilian, 38 Romanian, 39 Spanish, 40 Russian, 41 Turkish, 42 Mongol, 43 Taiwanese 44 and southern Indian populations. 45 Negative association of AGT polymorphism with high blood pressure was identified in Greek, 46 Dutch 47 and Brazilian populations. 48 The present study identifies the significant differences in genotype and allele frequencies of M268T (rs699) in DM patients with and without nephropathy when compared with controls. The TT genotype and T allele was high in DM patients with nephropathy as compared with the control group and patients with DM without nephropathy.
On the basis of this finding our study may suggest that the DD genotype and D allele of the ACE gene and the TT genotype and T allele of the AGT gene are prevalent in DM patients with nephropathy as compared with controls.
Conclusion
From this study we may conclude that different ethnic groups show variations of polymorphism in (I/D) ACE and (M268T) AGT genes. In a Pakistani population the D allele of the ACE gene and T allele of the AGT gene are found to be associated with the development of nephropathy in patients with DM. However, the association of ACE (DD genotype and D allele) and AGT (TT genotype and T allele) were analyzed in only a limited number of patients. For the authentication of this study more extensive analysis may be required, which may help in the early treatment of renal insufficiency in DM. 
